NO911876D0 - Fotodynamisk inaktivering av virus i celleholdige blandinger. - Google Patents
Fotodynamisk inaktivering av virus i celleholdige blandinger.Info
- Publication number
- NO911876D0 NO911876D0 NO911876A NO911876A NO911876D0 NO 911876 D0 NO911876 D0 NO 911876D0 NO 911876 A NO911876 A NO 911876A NO 911876 A NO911876 A NO 911876A NO 911876 D0 NO911876 D0 NO 911876D0
- Authority
- NO
- Norway
- Prior art keywords
- virus
- inactivation
- composition
- cell
- viruses
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title abstract 7
- 230000002779 inactivation Effects 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 5
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000000415 inactivating effect Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 230000001717 pathogenic effect Effects 0.000 abstract 2
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 230000003834 intracellular effect Effects 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 230000014759 maintenance of location Effects 0.000 abstract 1
- 239000007800 oxidant agent Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0029—Radiation
- A61L2/0052—Visible light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0023—Agression treatment or altering
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
- A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/08—Radiation
- A61L2/10—Ultraviolet radiation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
- C12N7/06—Inactivation or attenuation by chemical treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
- A61L2202/20—Targets to be treated
- A61L2202/22—Blood or products thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20211—Vesiculovirus, e.g. vesicular stomatitis Indiana virus
- C12N2760/20261—Methods of inactivation or attenuation
- C12N2760/20263—Methods of inactivation or attenuation by chemical treatment
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/524,208 US5120649A (en) | 1990-05-15 | 1990-05-15 | Photodynamic inactivation of viruses in blood cell-containing compositions |
Publications (3)
Publication Number | Publication Date |
---|---|
NO911876D0 true NO911876D0 (no) | 1991-05-14 |
NO911876L NO911876L (no) | 1991-11-18 |
NO308749B1 NO308749B1 (no) | 2000-10-23 |
Family
ID=24088240
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO911876A NO308749B1 (no) | 1990-05-15 | 1991-05-14 | FremgangsmÕte for inaktivering av et ekstracellulært lipidinnkapslet, patogent virus |
Country Status (11)
Country | Link |
---|---|
US (1) | US5120649A (no) |
EP (1) | EP0457196B1 (no) |
JP (1) | JP2831155B2 (no) |
KR (1) | KR0180917B1 (no) |
AT (1) | ATE204602T1 (no) |
AU (1) | AU660411B2 (no) |
CA (1) | CA2042494C (no) |
DE (1) | DE69132696T2 (no) |
FI (1) | FI911389A (no) |
NO (1) | NO308749B1 (no) |
ZA (1) | ZA913513B (no) |
Families Citing this family (80)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5109016A (en) * | 1988-05-23 | 1992-04-28 | Georgia State University Foundation, Inc. | Method for inhibiting infection or replication of human immunodeficiency virus with porphyrin and phthalocyanine antiviral compositions |
US5571666A (en) | 1988-10-28 | 1996-11-05 | Oklahoma Medical Research Foundation | Thiazine dyes used to inactivate HIV in biological fluids |
US6187572B1 (en) | 1990-04-16 | 2001-02-13 | Baxter International Inc. | Method of inactivation of viral and bacterial blood contaminants |
US5418130A (en) * | 1990-04-16 | 1995-05-23 | Cryopharm Corporation | Method of inactivation of viral and bacterial blood contaminants |
US5798238A (en) * | 1990-04-16 | 1998-08-25 | Baxter International Inc. | Method of inactivation of viral and bacterial blood contaminants with quinolines as photosensitizer |
US5955256A (en) * | 1990-04-16 | 1999-09-21 | Baxter International Inc. | Method of inactivation of viral and bacterial blood contaminants |
US5545516A (en) * | 1990-05-01 | 1996-08-13 | The American National Red Cross | Inactivation of extracellular enveloped viruses in blood and blood components by phenthiazin-5-ium dyes plus light |
US5981163A (en) * | 1990-05-15 | 1999-11-09 | New York Blood Center, Inc. | Process for the sterilization of biological compositions using irradiation and quenchers of type I and type II photodynamic reactions |
US6077659A (en) * | 1990-05-15 | 2000-06-20 | New York Blood Center, Inc. | Vitamin E and derivatives thereof prevent potassium ion leakage and other types of damage in red cells that are virus sterilized by phthalocyanines and light |
US5712086A (en) * | 1990-05-15 | 1998-01-27 | New York Blood Center, Inc. | Process for transfusing cell containing fractions sterilized with radiation and a quencher of type I and type II photodynamic reactions |
US5232844A (en) * | 1990-05-15 | 1993-08-03 | New York Blood Center | Photodynamic inactivation of viruses in cell-containing compositions |
US5658722A (en) * | 1990-05-15 | 1997-08-19 | New York Blood Center, Inc. | Process for the sterilization of biological compositions using UVA1 irradiation |
CA2089005C (en) * | 1991-06-21 | 1999-01-19 | John Chapman | Method for inactivating pathogens in a body fluid |
IL104530A0 (en) * | 1992-01-27 | 1993-05-13 | Cryopharm Corp | Method of inactivation of viral and bacterial blood contaminants |
TW235298B (no) * | 1992-02-27 | 1994-12-01 | Ciba Geigy | |
WO1996014740A1 (en) | 1992-03-02 | 1996-05-23 | Cerus Corporation | Synthetic media for blood components |
US6433343B1 (en) * | 1992-03-02 | 2002-08-13 | Cerus Corporation | Device and method for photoactivation |
DE69434445T2 (de) * | 1993-05-28 | 2006-05-18 | New York Blood Center, Inc. | Verfahren zur sterilisation biologischer zusammensetzungen und das dabei erhaltene produkt |
US6420570B1 (en) | 1993-06-28 | 2002-07-16 | Cerus Corporation | Psoralen compounds |
US5556993A (en) | 1993-06-28 | 1996-09-17 | Steritech, Inc. | Compounds for the photodecontamination of pathogens in blood |
US5399719A (en) | 1993-06-28 | 1995-03-21 | Steritech, Inc. | Compounds for the photodecontamination of pathogens in blood |
US5362442A (en) * | 1993-07-22 | 1994-11-08 | 2920913 Canada Inc. | Method for sterilizing products with gamma radiation |
GB9317881D0 (en) * | 1993-08-27 | 1993-10-13 | Secr Defence | Photosensitizers |
US5438192A (en) * | 1993-12-09 | 1995-08-01 | The United States Of America As Represented By The Secretary Of The Army | Photodynamic protein-based photodetector and photodetector system for image detection and processing |
US5527704A (en) * | 1994-12-06 | 1996-06-18 | Baxter International Inc. | Apparatus and method for inactivating viral contaminants in body fluids |
US5637451A (en) * | 1995-03-29 | 1997-06-10 | New York Blood Center, Inc. | Photodynamic treatment of red blood cells with phthalocyanines and red light at higher light fluence rates is protective of red blood cells |
CA2221716A1 (en) * | 1995-05-19 | 1996-11-21 | New York Blood Center, Inc. | Methods of use of phthalocyanines to inactivate blood borne parasites |
US6235508B1 (en) | 1995-06-07 | 2001-05-22 | Baxter International Inc. | Method of inactivation of viral and bacterial blood contaminants |
US6114108A (en) * | 1995-08-29 | 2000-09-05 | V.I. Technologies, Inc. | Methods and compositions for the selective modification of viral nucleic acids |
US20040048235A1 (en) * | 1995-08-29 | 2004-03-11 | V.I. Technologies, Inc. | Methods and compositions for the selective modification of nucleic acids |
US20040053208A1 (en) * | 1995-08-29 | 2004-03-18 | V. I. TECHNOLOGIES, Inc. | Methods to selectively inactivate parasites in biological compositions |
US6136586A (en) * | 1995-08-29 | 2000-10-24 | Vi Technologies, Inc. | Methods for the selective modification of viral nucleic acids |
AU723016B2 (en) * | 1995-11-06 | 2000-08-17 | New York Blood Center, Inc., The | Viral inactivation treatment of red blood cells using phthalocyanines and red light |
US5895786A (en) * | 1996-05-08 | 1999-04-20 | New York Blood Center, Inc. | Method for treating viral infections |
US6159733A (en) * | 1996-06-20 | 2000-12-12 | New York Blood Center, Inc. | Method for photoinactivating malignant cells |
US5891705A (en) * | 1997-04-08 | 1999-04-06 | Pentose Pharmaceuticals, Inc. | Method for inactivating a virus |
US6482585B2 (en) * | 1997-04-16 | 2002-11-19 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Storage and maintenance of blood products including red blood cells and platelets |
US6103706A (en) * | 1997-04-29 | 2000-08-15 | New York Blood Center, Inc. | Methods for treating viral infections |
NL1006219C2 (nl) * | 1997-06-04 | 1998-12-07 | Univ Leiden | Werkwijze voor het met licht inactiveren van virussen in een cellenbevattende vloeistof. |
US6093564A (en) * | 1997-10-03 | 2000-07-25 | V.I. Technologies, Inc. | Methods and compositions for the selective modification of nucleic acids |
US6352695B1 (en) * | 1997-10-03 | 2002-03-05 | V.I. Technologies, Inc. | Methods and compositions for the selective modification of nucleic acids |
ES2210846T3 (es) * | 1997-11-20 | 2004-07-01 | Cerus Corporation | Nuevos psoralenos para inactivar agentes patogenos. |
JP4643004B2 (ja) | 1998-01-06 | 2011-03-02 | シーラス コーポレイション | 生体材料中の病原体不活性化剤をクエンチするための方法 |
US6248733B1 (en) | 1998-01-09 | 2001-06-19 | 3M Innovative Properties Company | Method for limiting the growth of microorganisms using metal-containing compounds |
US6369048B1 (en) | 1998-01-12 | 2002-04-09 | V.I. Technologies, Inc. | Methods and compositions for inactivating viruses |
WO1999043790A1 (en) * | 1998-02-26 | 1999-09-02 | Hemasure Inc. | Method and apparatus for irradiating a biological fluid |
US6277337B1 (en) | 1998-07-21 | 2001-08-21 | Gambro, Inc. | Method and apparatus for inactivation of biological contaminants using photosensitizers |
US20030215784A1 (en) * | 1998-07-21 | 2003-11-20 | Dumont Larry Joe | Method and apparatus for inactivation of biological contaminants using photosensitizers |
US6258577B1 (en) | 1998-07-21 | 2001-07-10 | Gambro, Inc. | Method and apparatus for inactivation of biological contaminants using endogenous alloxazine or isoalloxazine photosensitizers |
US6617100B2 (en) | 1998-09-25 | 2003-09-09 | V.I. Technologies, Inc. | Solid phase quenching systems |
US6403359B1 (en) | 1998-09-25 | 2002-06-11 | V. I. TECHNOLOGIES, Inc. | Solid phase quenching systems |
US6565802B1 (en) | 1999-06-03 | 2003-05-20 | Baxter International Inc. | Apparatus, systems and methods for processing and treating a biological fluid with light |
US7068361B2 (en) | 1999-06-03 | 2006-06-27 | Baxter International | Apparatus, systems and methods for processing and treating a biological fluid with light |
US7220747B2 (en) * | 1999-07-20 | 2007-05-22 | Gambro, Inc. | Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer |
US6268120B1 (en) | 1999-10-19 | 2001-07-31 | Gambro, Inc. | Isoalloxazine derivatives to neutralize biological contaminants |
US7648699B2 (en) | 2000-06-02 | 2010-01-19 | Caridianbct Biotechnologies, Llc | Preventing transfusion related complications in a recipient of a blood transfusion |
US7985588B2 (en) | 2000-06-02 | 2011-07-26 | Caridianbct Biotechnologies, Llc | Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light |
TW590780B (en) | 2000-06-02 | 2004-06-11 | Gambro Inc | Additive solutions containing riboflavin |
US9044523B2 (en) | 2000-06-15 | 2015-06-02 | Terumo Bct, Inc. | Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light |
US6432396B1 (en) | 2000-07-06 | 2002-08-13 | 3M Innovative Properties Company | Limiting the presence of microorganisms using polymer-bound metal-containing compositions |
US6548241B1 (en) | 2000-11-28 | 2003-04-15 | Gambro, Inc. | Storage solution containing photosensitizer for inactivation of biological contaminants |
US20030228564A1 (en) * | 2001-05-30 | 2003-12-11 | Edrich Richard Alan | Nitric oxide in a pathogen inactivation process |
US20060269907A1 (en) * | 2003-06-04 | 2006-11-30 | American National Red Cross | Decontamination of biological fluids using diphenylpyrilium compounds |
US6881573B2 (en) * | 2003-09-12 | 2005-04-19 | Allan L. Louderback | Augmented solvent/detergent method for inactivating enveloped and non-enveloped viruses |
US7632078B2 (en) * | 2003-10-30 | 2009-12-15 | Deka Products Limited Partnership | Pump cassette bank |
CN101094692A (zh) * | 2004-10-29 | 2007-12-26 | 塞鲁斯公司 | 用于红细胞灭活过程的改进的猝灭方法 |
EP1767225A1 (en) * | 2005-09-21 | 2007-03-28 | Insense Limited | Method for stabilisation of a protein solution by addition of hydroxyl radical quenchers and its sterilisation by ionising radiation |
US9358292B2 (en) | 2007-04-08 | 2016-06-07 | Immunolight, Llc | Methods and systems for treating cell proliferation disorders |
JP5207436B2 (ja) * | 2007-05-22 | 2013-06-12 | 国立大学法人埼玉大学 | 撮像素子およびその製造方法 |
CN101868255A (zh) * | 2007-08-01 | 2010-10-20 | 科安比司特生物技术有限责任公司 | 全血的病原体灭活 |
US20090104212A1 (en) * | 2007-08-06 | 2009-04-23 | Immunolight | Methods and systems for treating cell proliferation disorders using two-photon simultaneous absorption |
WO2009026073A1 (en) * | 2007-08-22 | 2009-02-26 | Caridianbct Biotechnologies, Llc | Prevention of transfusion related acute lung injury using riboflavin and light |
AR070461A1 (es) | 2008-02-21 | 2010-04-07 | Immunolight Llc | Metodos y sistemas para tratar trastornos de proliferacion celular usando terapia fotoespectral mejorada con plasmonicos (pepst) y fototerapia mejorada con excitones plasmones (epep). composiciones. |
US9907976B2 (en) | 2011-07-08 | 2018-03-06 | Immunolight, Llc | Phosphors and scintillators for light stimulation within a medium |
EP3300744A1 (en) | 2008-04-04 | 2018-04-04 | Immunolight, Llc. | Non-invasive systems and methods for in-situ photobiomodulation |
JP5916383B2 (ja) | 2008-04-09 | 2016-05-11 | シーラス コーポレイション | 赤血球病原体の不活化のための改善されたクエンチング方法 |
DE102008060549A1 (de) | 2008-12-04 | 2010-06-10 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung |
WO2012075041A2 (en) | 2010-11-29 | 2012-06-07 | New York Blood Center, Inc. | Method of blood pooling and storage |
US20140127077A1 (en) | 2012-11-05 | 2014-05-08 | Gail Rock | Device and method for sterilization of instruments and surfaces |
US20190070323A1 (en) * | 2015-10-02 | 2019-03-07 | The US of America, as represented by the Secretary Dept. of Health and Human Servics | Inactivation of pathogens in ex vivo blood products in storage bags using visible light |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4008136A (en) * | 1974-08-09 | 1977-02-15 | Temple University | Process for the treatment of waste water by heterogeneous photosensitized oxidation |
FR2387658A1 (fr) * | 1977-03-25 | 1978-11-17 | Ciba Geigy Ag | Procede pour combattre les microorganismes |
US4568542A (en) * | 1981-06-09 | 1986-02-04 | Lee Biomolecular Research Laboratories, Inc. | Vaccine compositions |
DE3483751D1 (de) * | 1983-05-02 | 1991-01-31 | Diamond Scient Co | Photochemische entkeimungsbehandlung von vollem blut oder blutbestandteilen. |
US4693981A (en) * | 1983-12-20 | 1987-09-15 | Advanced Genetics Research Institute | Preparation of inactivated viral vaccines |
US4791062A (en) * | 1985-02-28 | 1988-12-13 | Diamond Scientific Co. | FVR vaccine |
US4775625A (en) * | 1986-11-21 | 1988-10-04 | The Medical College Of Wisconsin, Inc. | Inactivating enveloped viruses with a merocyanine dye |
US4920143A (en) * | 1987-04-23 | 1990-04-24 | University Of British Columbia | Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents |
US4878891A (en) * | 1987-06-25 | 1989-11-07 | Baylor Research Foundation | Method for eradicating infectious biological contaminants in body tissues |
US5192788A (en) * | 1988-05-23 | 1993-03-09 | Georgia State University Foundation, Inc. | Porphyrin antiviral compositions |
IL92996A (en) * | 1989-01-10 | 1996-06-18 | Bisaccia Emil | Photovoltaic compounds as drugs for the treatment of viral infections and a method for the production of vaccines |
US5041078A (en) * | 1989-03-06 | 1991-08-20 | Baylor Research Foundation, A Nonprofit Corporation Of The State Of Texas | Photodynamic viral deactivation with sapphyrins |
US4935498A (en) * | 1989-03-06 | 1990-06-19 | Board Of Regents, The University Of Texas System | Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles |
DE3930510A1 (de) * | 1989-09-13 | 1991-03-21 | Blutspendedienst Dt Rote Kreuz | Verfahren zur inaktivierung von viren in blut und blutprodukten |
-
1990
- 1990-05-15 US US07/524,208 patent/US5120649A/en not_active Expired - Lifetime
-
1991
- 1991-03-21 FI FI911389A patent/FI911389A/fi unknown
- 1991-05-08 ZA ZA913513A patent/ZA913513B/xx unknown
- 1991-05-09 AT AT91107556T patent/ATE204602T1/de not_active IP Right Cessation
- 1991-05-09 EP EP91107556A patent/EP0457196B1/en not_active Expired - Lifetime
- 1991-05-09 DE DE69132696T patent/DE69132696T2/de not_active Expired - Fee Related
- 1991-05-10 AU AU76469/91A patent/AU660411B2/en not_active Ceased
- 1991-05-14 CA CA002042494A patent/CA2042494C/en not_active Expired - Fee Related
- 1991-05-14 NO NO911876A patent/NO308749B1/no not_active IP Right Cessation
- 1991-05-14 JP JP3109327A patent/JP2831155B2/ja not_active Expired - Fee Related
- 1991-05-15 KR KR1019910007864A patent/KR0180917B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FI911389A (fi) | 1991-11-16 |
DE69132696T2 (de) | 2002-06-20 |
EP0457196A3 (en) | 1992-03-04 |
AU7646991A (en) | 1991-11-21 |
CA2042494C (en) | 1998-12-01 |
US5120649A (en) | 1992-06-09 |
AU660411B2 (en) | 1995-06-29 |
FI911389A0 (fi) | 1991-03-21 |
DE69132696D1 (de) | 2001-09-27 |
EP0457196B1 (en) | 2001-08-22 |
CA2042494A1 (en) | 1991-11-16 |
JP2831155B2 (ja) | 1998-12-02 |
NO911876L (no) | 1991-11-18 |
KR910019633A (ko) | 1991-12-19 |
JPH04226919A (ja) | 1992-08-17 |
NO308749B1 (no) | 2000-10-23 |
ATE204602T1 (de) | 2001-09-15 |
KR0180917B1 (ko) | 1999-04-01 |
ZA913513B (en) | 1992-04-29 |
EP0457196A2 (en) | 1991-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO911876L (no) | Fotodynamisk inaktivering av virus i celleholdige blandinger. | |
EP0562877A3 (en) | Cell fixative and method of staining cells without destroying the cell surface | |
DE69622466T2 (de) | Inaktivierung von Prionen in Bindegewebematerialen | |
ES2101700T3 (es) | Estructura absorbente. | |
IL96783A0 (en) | Ophthalmic compositions and methods for preserving and using same | |
FI955690A0 (fi) | Menetelmä biologisten seosten steriloimiseksi ja menetelmällä tuotettutuote | |
DE69623899D1 (de) | Behandlung von Tinnitus mit neuroprotektiven Wirkstoffen | |
AR246769A1 (es) | Fibras termosoldables, y articulos fabricados soldados termicamente y textiles no tejidos obtenidos de dichas fibras | |
BR9608776A (pt) | Processo de uso de ftalocianinas para inativar parasitas do sangue | |
ES2082872T3 (es) | Composiciones antiglaucoma que contienen 3-arilcarbonil-1-aminoalquil--1h-indol. | |
DE59509395D1 (de) | Verwendung von Lactamverbindungen als pharmazeutische Wirkstoffe | |
DE3769691D1 (de) | Substituierte oximether, ihre verwendung als bioregulatoren zur senkung des endogenen ethylenspiegels in pflanzen. | |
ATE59778T1 (de) | Verwendung von sulfonamidderivaten zur herstellung eines antivirusmittels. | |
BR9610932A (pt) | Processo para armazenar microorganismos, composição de microorganismos e utilização da mesma | |
ES2043884T3 (es) | Metodo de gran rendimiento para la preparacion de algodon a partir de celulas cultivadas. | |
DE69110570D1 (de) | Arzneimittel, enthaltend ein N6-substituiertes Adenosin-Derivat zur Behandlung von Hyperlipidämie oder Hypertriglyceridämie. | |
DE59407576D1 (de) | Verwendung von Etofibrat und pharmazeutische Zusammensetzungen, enthaltend Etofibrat, zur Behandlung der diabetischen Angio- und Retinopathie | |
Armando | [Enviromental risks assessment of raw logs importation into Mexico].[Spanish] |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN NOVEMBER 2002 |